<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Italian Bag 1: Crystal structures of the CDK5-p25 kinase with bound inhibitors Experiment number: MX-129</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Marina</forename><surname>Mapelli</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435 20141 Milan Italy</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Cataldo</forename><surname>Tarricone</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435 20141 Milan Italy</addrLine>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Experimental Oncology European Institute of Oncology</orgName>
								<address>
									<addrLine>Via Ripamonti 435 20141 Milan Italy</addrLine>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Italian Bag 1: Crystal structures of the CDK5-p25 kinase with bound inhibitors Experiment number: MX-129</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">E6BF3BAA25CF63713FFB24192C9595B9</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T21:56+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Background</head><p>CDK5 is a Cyclin-dependent Ser/Thr kinase acting in the central nervous system (CNS). Its activity requires the interaction with a protein known as p35. Deregulation of CDK5 activity as a consequence of proteolytic processing of the p35 sununit to a p25 moiety containing the C-terminal portion of p35 has been reported. It is deemed that CDK5 deregulation is important for the development of neuro-degenerative diseases such as amyotrophic lateral sclerosis and Alzheimer's disease. We have previously reported the crystal structure of the CDK5-p25 heterodimer <ref type="bibr" target="#b0">(Tarricone et al, 2001)</ref>. We are currently concentrating on the study of crystal structures of the heterodimeric enzyme with known and newly identified inhibitors of CDK5, to understand their mode of action, and to identify possible differences with other CDK-inhibitor interaction that may lead to the development of selective inhibitors.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>We have determined the crystal structures of several CDK inhibitors bound to the active site of CDK5, using a trigonal crystal form with greatly improved properties relative to the initially identified monoclinic crystal form <ref type="bibr" target="#b0">(Tarricone et al 2001)</ref>. A manuscript describing the refined structures of three complexes of CDK5-p25 with small molecule inhibitors (Indirubin, Roscovitine, Aloisine) has been submitted for publication. We have also started a collaboration with the group of Ken Kosick (Harvard Medical School, Boston, USA) aimed at identifying non-active site inhibitors of this kinase, and at characterizing the crystal structures of the most promising leads. Dataset from a first batch of these inhibitors have been collected.</p></div>		</body>
		<back>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>from: 10/07/2003 to: 10/07/2003 from: 08/02/2004 to: 08/02/2004</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Structure and Regulation of the CDK5-p25nck5a Complex</title>
		<author>
			<persName><forename type="first">Cataldo</forename><surname>Tarricone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rani</forename><surname>Dhavan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Junmin</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Liliana</forename><forename type="middle">B</forename><surname>Areces</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Li-Huei</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1097-2765(01)00343-4</idno>
	</analytic>
	<monogr>
		<title level="j">Molecular Cell</title>
		<title level="j" type="abbrev">Molecular Cell</title>
		<idno type="ISSN">1097-2765</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="657" to="669" />
			<date type="published" when="2001-09">2001</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Tarricone C, Dhavan R, Peng J, Areces L, Tsai L-H, and Musacchio A (2001) Structure and regulation of the CDK5-p25 complex, Molecular Cell 8, 657-669</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The Structural Perspective on CDK5</title>
		<author>
			<persName><forename type="first">Marina</forename><surname>Mapelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
		</author>
		<idno type="DOI">10.1159/000074617</idno>
	</analytic>
	<monogr>
		<title level="j">Neurosignals</title>
		<title level="j" type="abbrev">Neurosignals</title>
		<idno type="ISSN">1424-862X</idno>
		<idno type="ISSNe">1424-8638</idno>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">4-5</biblScope>
			<biblScope unit="page" from="164" to="172" />
			<date type="published" when="2003">2003</date>
			<publisher>S. Karger AG</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Mapelli M &amp; Musacchio A (2003) The Structural Perspective on CDK5, NeuroSignals 12:164-72</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins</title>
		<author>
			<persName><forename type="first">Laurent</forename><surname>Meijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alexios-Leandros</forename><surname>Skaltsounis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Prokopios</forename><surname>Magiatis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Panagiotis</forename><surname>Polychronopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Marie</forename><surname>Knockaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Maryse</forename><surname>Leost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Xiaozhou</forename><forename type="middle">P</forename><surname>Ryan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Claudia</forename><forename type="middle">Alin</forename><surname>Vonica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ali</forename><surname>Brivanlou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rana</forename><surname>Dajani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Claudia</forename><surname>Crovace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cataldo</forename><surname>Tarricone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Mark</forename><surname>Roe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Laurence</forename><surname>Pearl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Paul</forename><surname>Greengard</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.chembiol.2003.11.010</idno>
	</analytic>
	<monogr>
		<title level="j">Chemistry &amp; Biology</title>
		<title level="j" type="abbrev">Chemistry &amp; Biology</title>
		<idno type="ISSN">1074-5521</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1255" to="1266" />
			<date type="published" when="2003-12">2003</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Meijer L, Skaltsounis A-L, Magiatis P, Polychronopoulos P, Knockaert M, Leost M, Ryan XP, Vonica CA, Brivanlou A, Dajani R, Crovace C, Tarricone C, Musacchio A, Roe SM, Pearl L, and Greengard P (2003) GSK-3 selective inhibitors derived from Tyrian purple indirubins, Chem. Biol, 10, 1255-1266</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Development of an Assay to Screen for Inhibitors of Tau Phosphorylation by Cdk5</title>
		<author>
			<persName><forename type="first">Jae</forename><forename type="middle">Suk</forename><surname>Ahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Marina</forename><surname>Mapelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jake</forename><surname>Ni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Leonard</forename><surname>Scinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ross</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kenneth</forename><forename type="middle">S</forename><surname>Kosik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Li-An</forename><surname>Yeh</surname></persName>
		</author>
		<idno type="DOI">10.1177/1087057103260594</idno>
	</analytic>
	<monogr>
		<title level="j">SLAS Discovery</title>
		<title level="j" type="abbrev">SLAS Discovery</title>
		<idno type="ISSN">2472-5552</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="122" to="131" />
			<date type="published" when="2004-03">2004</date>
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Ahn JS, Musacchio A, Mapelli M, Ni J, Scinto L, Stein R, Kosik KS, Yeh L-A (2004) , Development of an Assay to Screen for Inhibitors of Tau Phosphorylation by Cdk5, Journal of Biomolecular Screening, 9, 122- 131</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Structural Basis for the Synthesis of Indirubins as Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 and Cyclin-Dependent Kinases</title>
		<author>
			<persName><forename type="first">Panagiotis</forename><surname>Polychronopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Prokopios</forename><surname>Magiatis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alexios-Leandros</forename><surname>Skaltsounis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Vassilios</forename><surname>Myrianthopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Emmanuel</forename><surname>Mikros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Aldo</forename><surname>Tarricone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Mark</forename><surname>Roe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Laurence</forename><surname>Pearl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Maryse</forename><surname>Leost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Paul</forename><surname>Greengard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Laurent</forename><surname>Meijer</surname></persName>
		</author>
		<idno type="DOI">10.1021/jm031016d</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Medicinal Chemistry</title>
		<title level="j" type="abbrev">J. Med. Chem.</title>
		<idno type="ISSN">0022-2623</idno>
		<idno type="ISSNe">1520-4804</idno>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="935" to="946" />
			<date type="published" when="2004-01-08">2004</date>
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Polychronopoulos P, Magiatis P, Skaltsounis AL, Myrianthopoulos V, Mikros E, Tarricone A, Musacchio A, Roe SM, Pearl L, Leost M, Greengard P, Meijer L. (2004) Structural Basis for the Synthesis of Indirubins as Potent and Selective Inhibitors of Glycogen Synthase Kinase-3 and Cyclin-Dependent Kinases. J Med Chem. 12, 935-946</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Mechanism of CDK5/p25 Binding by CDK Inhibitors</title>
		<author>
			<persName><forename type="first">Marina</forename><surname>Mapelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lucia</forename><surname>Massimiliano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Claudia</forename><surname>Crovace</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Markus</forename><forename type="middle">A</forename><surname>Seeliger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Li-Huei</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Laurent</forename><surname>Meijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrea</forename><surname>Musacchio</surname></persName>
		</author>
		<idno type="DOI">10.1021/jm049323m</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Medicinal Chemistry</title>
		<title level="j" type="abbrev">J. Med. Chem.</title>
		<idno type="ISSN">0022-2623</idno>
		<idno type="ISSNe">1520-4804</idno>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="671" to="679" />
			<date type="published" when="2005-01-06" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
	<note>submitted</note>
	<note type="raw_reference">Mapelli M, Massimiliano L, Crovace C, Seeliger MA, Tsai L-H, Meijer L and Musacchio A, Mechanism of CDK5/p25 binding by CDK inhibitors, submitted</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
